US Patent Issued to CENTESSA PHARMACEUTICALS (UK) on April 29 for "Compounds and their use for the treatment of alpha1-antitrypsin deficiency" (British Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,402, issued on April 29, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain).

"Compounds and their use for the treatment of alpha1-antitrypsin deficiency" was invented by Nigel Ramsden (Cambridge, Great Britain), David John Fox (Coventry, Great Britain), James Andrew Huntington (Cheshire, Great Britain) and James Michael Tomlinson (Babraham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to specified benzamide compounds of formula (1), and pharmaceutical compositions containing the compounds. The compounds may be inducers of Alpha1-antitrypsin (A1AT), and may be used in the treatment of a...